APLN and cardiovascular disorder: Apelin and its receptors (APJ) are thought to be involved in the regulation of numerous physiological processes [208], making the Apelin/APJ axis a promising target for implementing novel therapeutic strategies for a range of metabolic and cardiovascular diseases [209,210].